Trial intelligence / Profile preview

Tamsulosin vs Tamsulosin + Silodosin for BPH

NCT07815379Phase 4Active, not recruiting

Sponsor
Mansoura University
Start
Oct 2025
Primary completion
Oct 2026
Countries
1
01

Overview

A Phase 4 trial of silodosin in benign prostatic hyperplasia (BPH), sponsored by Mansoura University. Started Oct 2025; status: active, not recruiting.

02

Drugs

silodosin
03

Conditions

benign prostatic hyperplasia (BPH)

Beyond the preview

Go deeper on NCT07815379.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07815379.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call